Publicação

Management of hyperglycaemia in type 2 diabetic patients with Chronic Kidney Disease

Ver documento

Detalhes bibliográficos
Resumo:Diabetes is an increasingly common disease with an important negative impact on patient’s morbidityand mortality, being the main cause of end stage renal disease. Management of the diabetic patient with chronic kidney disease poses additional challenges, namely with respect to defining glycaemic targets and in the therapeutics employed to achieve them. The authors review the state of the art evidence about the use of antihyperglycaemic agents in type 2 diabetes, from the perspective of a chronic kidney disease patient’s health care provider.
Autores principais:Coelho,Sílvia
Outros Autores:Carrilho,Patrícia; Inchaustegui,Luís
Assunto:Chronic kidney disease diabetes hypoglycaemic agents
Ano:2013
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Fundação para a Ciência e Tecnologia
Idioma:inglês
Origem:SciELO Portugal
Descrição
Resumo:Diabetes is an increasingly common disease with an important negative impact on patient’s morbidityand mortality, being the main cause of end stage renal disease. Management of the diabetic patient with chronic kidney disease poses additional challenges, namely with respect to defining glycaemic targets and in the therapeutics employed to achieve them. The authors review the state of the art evidence about the use of antihyperglycaemic agents in type 2 diabetes, from the perspective of a chronic kidney disease patient’s health care provider.